Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004312 · ClinicalTrials.gov registry record
Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis
A clinical trial of Cystinosis, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT00004312 is a study of Cystinosis that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 400 participants, above the 105-participant average among 4 other Cystinosis trials with a reported enrollment target (281% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00004312, a study of Cystinosis, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVES: I. Establish a computerized databank to monitor the progress of patients with cystinosis treated with cysteamine. II. Track and monitor all patients including renal transplant, dialysis and post renal transplants.
Conditions Studied
Study Locations (1)
California
- University of California San Diego School of Medicine - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 1999-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004312
The ClinicalTrials.gov registry entry for NCT00004312 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 105-participant average among 4 other Cystinosis trials with a reported enrollment target (281% higher). The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystinosis appearing as the primary indexed condition, and to 0 interventions.
NCT00004312 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00004312 about?
NCT00004312 is a clinical study titled "Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis". OBJECTIVES: I. Establish a computerized databank to monitor the progress of patients with cystinosis treated with cysteamine. II. Track and monitor all patients including renal transplant, dialysis and post renal transplants.
What is the current status of trial NCT00004312?
This trial is currently completed. The enrollment target is 400 participants. The study started on 1999-10.
What conditions does trial NCT00004312 study?
This clinical trial studies the following conditions: Cystinosis.
Who is sponsoring clinical trial NCT00004312?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004312 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystinosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Use of Cysteamine in the Treatment of Cystinosis
RECRUITING
-
Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
RECRUITING · Phase 1
-
Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)
COMPLETED · Phase 3
-
Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.